Pressemelding

Paris, June 12, 2005 Dear Madam, Dear Sir: You would find attached a press release from Professor André Scheen M.D., Academic Hospital of Liege, University of Liege, Belgium, Principal Investigator of the RIO-Diabetes study, issued today at the annual congress of the American Diabetes Association in San Diego, California : “RIMONABANT STUDY SHOWS SIGNIFICANT IMPROVEMENTS IN HbA1c AND CARDIOMETABOLIC RISK FACTORS IN PEOPLE WITH TYPE 2 DIABETES” We remind you that rimonabant has been submitted for registration in the US and in Europe, during the 2nd quarter of this year. Best regards, Media Relations Department. +33 1 53 77 40 76 ------------------------------------------------------------ Informasjonen er sendt gjennom Waymaker http://www.waymaker.no Nedenstående filer kan lastes ned: http://wpy.waymaker.net/client/waymaker1/WOLReleaseFile.aspx?id=107135&fn=wkr0001.pdf Pressemelding i pdf format